Katherine H. Campbell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katherine H. Campbell has a total of 385 co-authors. Here are the top co-authors by number of shared publications:
Christian M. Pettker
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine and Yale New Haven Hospital, 333 Cedar Street, P.O. Box 208063, New Haven, CT 06520-8063, United States
5 shared publications- Christian M. Pettker
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT
5 shared publications Heather S. Lipkind
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
4 shared publicationsDena Goffman
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, United States
3 shared publicationsJessica L. Illuzzi
Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
3 shared publications- Akiko Iwasaki
Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
2 shared publications
Latest Publications
Using the Electronic Medical Record to Correlate Patient‐Provider Perspectives in the Care of Black Individuals With High‐Risk Pregnancies
Background: The electronic medical record (EMR) is a mainstay of medical documentation but can be limited in its representation of patient perspectives. Given significant disparities in quality of care and health outcomes for Black pregnant individuals, we sought to correlate patient‐provider perspectives in the care of Black pregnant individuals with diabetes and/or hypertension to identify opportunities for quality improvement. Methods: We conducted a convergent mixed methods study, which correlated findings from in‐depth qualitative interviews exploring participants' pregnancy, delivery, and postpartum experiences with providers' medical documentation in the EMR through retrospective chart review. Participants self‐identified as Black ( N = 9), were on average 10.6 weeks postpartum, and had confirmed diagnoses of diabetes and/or hypertension during pregnancy or postpartum. Results: Through correlating interview responses with EMR documentation, we identified four themes: (1) Incomplete representation of positive and negative experiences in EMR documentation, (2) Concerns with acknowledgement of pain and pain management, (3) Perceived coercion and stereotyping with contraception counseling, and (4) Counseling around delivery planning: balancing autonomy and provider recommendations. While participants' described experiences were correlated to EMR documentation for some instances, we noted differences in patient and provider perspectives that impacted patients' perceived quality of care received. Discussion: We highlight limitations of using EMR alone as a tool to assess the quality of care for Black pregnant patients and propose a novel informed care model that encourages providers to center patient voices, assess personal biases, and consider patients' historical, personal, and community contexts while counseling patients with high‐risk pregnancies.
Using the Electronic Medical Record to Correlate Patient‐Provider Perspectives in the Care of Black Individuals With High‐Risk Pregnancies
Background: The electronic medical record (EMR) is a mainstay of medical documentation but can be limited in its representation of patient perspectives. Given significant disparities in quality of care and health outcomes for Black pregnant individuals, we sought to correlate patient‐provider perspectives in the care of Black pregnant individuals with diabetes and/or hypertension to identify opportunities for quality improvement. Methods: We conducted a convergent mixed methods study, which correlated findings from in‐depth qualitative interviews exploring participants' pregnancy, delivery, and postpartum experiences with providers' medical documentation in the EMR through retrospective chart review. Participants self‐identified as Black ( N = 9), were on average 10.6 weeks postpartum, and had confirmed diagnoses of diabetes and/or hypertension during pregnancy or postpartum. Results: Through correlating interview responses with EMR documentation, we identified four themes: (1) Incomplete representation of positive and negative experiences in EMR documentation, (2) Concerns with acknowledgement of pain and pain management, (3) Perceived coercion and stereotyping with contraception counseling, and (4) Counseling around delivery planning: balancing autonomy and provider recommendations. While participants' described experiences were correlated to EMR documentation for some instances, we noted differences in patient and provider perspectives that impacted patients' perceived quality of care received. Discussion: We highlight limitations of using EMR alone as a tool to assess the quality of care for Black pregnant patients and propose a novel informed care model that encourages providers to center patient voices, assess personal biases, and consider patients' historical, personal, and community contexts while counseling patients with high‐risk pregnancies.
- Open Access
- 12 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4720
Adherence to Labor Arrest and Failed Induction of Labor Guidelines: The Impact of a Quality-Improvement Educational Intervention
Background/Objective: To evaluate adherence to labor arrest and failed induction of labor (IOL) criteria in nulliparous, term, singleton, and vertex (NTSV) cesarean deliveries at an academic medical center and to measure the impact of a quality-improvement educational initiative that focused on obstetric provider education of modern labor arrest and failed IOL criteria. Methods: This is a retrospective cohort study using electronic health record (EHR) data with a pre- (1 September 2018–30 September 2019) and post-intervention (1 October 2019–31 March 2020) study design of all NTSV cesarean deliveries for labor arrest or failed IOL performed at an academic medical center in the northeastern United States. The quality-improvement educational intervention consisted of the distribution of educational pocket cards outlining modern labor arrest and failed IOL criteria to obstetric providers. Outcomes included adherence to labor arrest and failed IOL criteria pre- and post-intervention with secondary outcomes evaluating adherence by provider type (Maternal–Fetal Medicine (MFM) or generalist obstetrician). Descriptive and bivariate statistics were used in the analysis. Results: Pre-intervention, 272 NTSV cesarean deliveries were performed for labor arrest or failed IOL versus 92 post-intervention. Adherence improved post-intervention amongst failed IOL (OR 6.5, CI 1.8–23.8), first-stage arrest (OR 4.5, CI 2.2–10.8) and second-stage arrest (OR 3.7, CI 1.5–9.4). When comparing provider type, MFM physicians were more likely to be adherent to labor arrest and failed IOL criteria compared to generalist obstetricians pre-intervention (OR 3.1, CI 1.7–5.5); however, post-intervention, there was no longer a difference in adherence (OR 3.3, CI 0.9–12.3). Conclusions: Adherence to labor arrest criteria was suboptimal in the pre-intervention period; however, a targeted quality-improvement educational intervention improved adherence rates to labor arrest and failed IOL criteria among obstetric providers.
- 12 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4720
Open AccessAdherence to Labor Arrest and Failed Induction of Labor Guidelines: The Impact of a Quality-Improvement Educational Intervention
Background/Objective: To evaluate adherence to labor arrest and failed induction of labor (IOL) criteria in nulliparous, term, singleton, and vertex (NTSV) cesarean deliveries at an academic medical center and to measure the impact of a quality-improvement educational initiative that focused on obstetric provider education of modern labor arrest and failed IOL criteria. Methods: This is a retrospective cohort study using electronic health record (EHR) data with a pre- (1 September 2018–30 September 2019) and post-intervention (1 October 2019–31 March 2020) study design of all NTSV cesarean deliveries for labor arrest or failed IOL performed at an academic medical center in the northeastern United States. The quality-improvement educational intervention consisted of the distribution of educational pocket cards outlining modern labor arrest and failed IOL criteria to obstetric providers. Outcomes included adherence to labor arrest and failed IOL criteria pre- and post-intervention with secondary outcomes evaluating adherence by provider type (Maternal–Fetal Medicine (MFM) or generalist obstetrician). Descriptive and bivariate statistics were used in the analysis. Results: Pre-intervention, 272 NTSV cesarean deliveries were performed for labor arrest or failed IOL versus 92 post-intervention. Adherence improved post-intervention amongst failed IOL (OR 6.5, CI 1.8–23.8), first-stage arrest (OR 4.5, CI 2.2–10.8) and second-stage arrest (OR 3.7, CI 1.5–9.4). When comparing provider type, MFM physicians were more likely to be adherent to labor arrest and failed IOL criteria compared to generalist obstetricians pre-intervention (OR 3.1, CI 1.7–5.5); however, post-intervention, there was no longer a difference in adherence (OR 3.3, CI 0.9–12.3). Conclusions: Adherence to labor arrest criteria was suboptimal in the pre-intervention period; however, a targeted quality-improvement educational intervention improved adherence rates to labor arrest and failed IOL criteria among obstetric providers.
- Open Access
- 22 May 2023
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 20 (Supplement)
(331) Whole Exome Sequencing Identifies Rare CFTR Variant in Two Brothers with CBAVD and CUAVD
Introduction: Congenital Bilateral Absence of the Vas Deferens (CBAVD) is a condition leading to obstructive azoospermia and male infertility. CBAVD is associated with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Congenital Unilateral Absence of the Vas Deferens (CUAVD), where only one vas deferens is missing, is also associated with mutations in the CFTR gene. However, the genetic causes of both conditions are not fully understood and warrant further investigation. We present two brothers, one with CBAVD and one with CUAVD, who were subjected to whole exome sequencing. Objective: To assess genetic similarities using whole exome sequencing between two brothers with differing reproductive capacities. Methods: Whole exome sequencing was performed in two brothers. Subject A was 39-year-old-male who had previously fathered a child and was diagnosed with CUAVD during his vasectomy. Subject B was a 37-year-old male diagnosed with CBAVD, and genetic testing significant for one copy of a mutated cystic fibrosis gene (unaffected CF carrier). Whole blood was collected. DNA was extracted and quality assessed. Finally, whole exome sequencing was completed. Results: Whole exome sequencing results were subjected to annotation and filtering. Both subjects were noted to share a rare mutation in the CFTR gene (p.R347H). CFTR mutations are the most common cause of CBAVD and have also been linked to CUAVD. However, this is a unique case of two brothers with the same genetic mutation but different phenotypic expressions of the mutation. Conclusions: We have identified a rare CFTR variant (p.R347H) in two brothers with different reproductive capacities. We present evidence that absence of the vas deferens (unilateral or bilateral) may be associated with CFTR mutations, even in the absence of diagnosed cystic fibrosis. Understanding the phenotypic spectrum of CFTR gene mutations is pivotal to treating associated male infertility. Disclosure: Any of the authors act as a consultant, employee or shareholder of an industry for: Acerus Pharmaceuticals, Boston Scientific, Coloplast, Endo Pharmaceuticals, Empower Pharmacy, Nestle Health, Olympus, Hims Inc.
- 22 May 2023
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 20 (Supplement)
Open Access(331) Whole Exome Sequencing Identifies Rare CFTR Variant in Two Brothers with CBAVD and CUAVD
Introduction: Congenital Bilateral Absence of the Vas Deferens (CBAVD) is a condition leading to obstructive azoospermia and male infertility. CBAVD is associated with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Congenital Unilateral Absence of the Vas Deferens (CUAVD), where only one vas deferens is missing, is also associated with mutations in the CFTR gene. However, the genetic causes of both conditions are not fully understood and warrant further investigation. We present two brothers, one with CBAVD and one with CUAVD, who were subjected to whole exome sequencing. Objective: To assess genetic similarities using whole exome sequencing between two brothers with differing reproductive capacities. Methods: Whole exome sequencing was performed in two brothers. Subject A was 39-year-old-male who had previously fathered a child and was diagnosed with CUAVD during his vasectomy. Subject B was a 37-year-old male diagnosed with CBAVD, and genetic testing significant for one copy of a mutated cystic fibrosis gene (unaffected CF carrier). Whole blood was collected. DNA was extracted and quality assessed. Finally, whole exome sequencing was completed. Results: Whole exome sequencing results were subjected to annotation and filtering. Both subjects were noted to share a rare mutation in the CFTR gene (p.R347H). CFTR mutations are the most common cause of CBAVD and have also been linked to CUAVD. However, this is a unique case of two brothers with the same genetic mutation but different phenotypic expressions of the mutation. Conclusions: We have identified a rare CFTR variant (p.R347H) in two brothers with different reproductive capacities. We present evidence that absence of the vas deferens (unilateral or bilateral) may be associated with CFTR mutations, even in the absence of diagnosed cystic fibrosis. Understanding the phenotypic spectrum of CFTR gene mutations is pivotal to treating associated male infertility. Disclosure: Any of the authors act as a consultant, employee or shareholder of an industry for: Acerus Pharmaceuticals, Boston Scientific, Coloplast, Endo Pharmaceuticals, Empower Pharmacy, Nestle Health, Olympus, Hims Inc.
- Open Access
SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface
Pregnant women appear to be at increased risk for severe outcomes associated with COVID-19, but the pathophysiology underlying this increased morbidity and its potential impact on the developing fetus is not well understood. In this study of pregnant women with and without COVID-19, we assessed viral and immune dynamics at the placenta during maternal SARS-CoV-2 infection. Amongst uninfected women, ACE2 was detected by immunohistochemistry in syncytiotrophoblast cells of the normal placenta during early pregnancy but was rarely seen in healthy placentas at full term. Term placentas from women infected with SARS-CoV-2, however, displayed a significant increase in ACE2 levels. Using immortalized cell lines and primary isolated placental cells, we determined the vulnerability of various placental cell types to direct infection by SARS-CoV-2 in vitro . Yet, despite the susceptibility of placental cells to SARS-CoV-2 infection, viral RNA was detected in the placentas of only a subset (∼13%) of women in this cohort. Through single cell transcriptomic analyses, we found that the maternal-fetal interface of SARS-CoV-2-infected women exhibited markers associated with pregnancy complications, such as preeclampsia, and robust immune responses, including increased activation of placental NK and T cells and increased expression of interferon-related genes. Overall, this study suggests that SARS-CoV-2 is associated with immune activation at the maternal-fetal interface even in the absence of detectable local viral invasion. While this likely represents a protective mechanism shielding the placenta from infection, inflammatory changes in the placenta may also contribute to poor pregnancy outcomes and thus warrant further investigation.
Open AccessSARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface
Pregnant women appear to be at increased risk for severe outcomes associated with COVID-19, but the pathophysiology underlying this increased morbidity and its potential impact on the developing fetus is not well understood. In this study of pregnant women with and without COVID-19, we assessed viral and immune dynamics at the placenta during maternal SARS-CoV-2 infection. Amongst uninfected women, ACE2 was detected by immunohistochemistry in syncytiotrophoblast cells of the normal placenta during early pregnancy but was rarely seen in healthy placentas at full term. Term placentas from women infected with SARS-CoV-2, however, displayed a significant increase in ACE2 levels. Using immortalized cell lines and primary isolated placental cells, we determined the vulnerability of various placental cell types to direct infection by SARS-CoV-2 in vitro . Yet, despite the susceptibility of placental cells to SARS-CoV-2 infection, viral RNA was detected in the placentas of only a subset (∼13%) of women in this cohort. Through single cell transcriptomic analyses, we found that the maternal-fetal interface of SARS-CoV-2-infected women exhibited markers associated with pregnancy complications, such as preeclampsia, and robust immune responses, including increased activation of placental NK and T cells and increased expression of interferon-related genes. Overall, this study suggests that SARS-CoV-2 is associated with immune activation at the maternal-fetal interface even in the absence of detectable local viral invasion. While this likely represents a protective mechanism shielding the placenta from infection, inflammatory changes in the placenta may also contribute to poor pregnancy outcomes and thus warrant further investigation.
- Top Cited PapersOpen Access
- 1 September 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (9) , 4947-4953
SARS–CoV-2 infection of the placenta
BACKGROUND. The effects of the novel coronavirus disease 2019 (COVID-19) in pregnancy remain relatively unknown. We present a case of second trimester pregnancy with symptomatic COVID-19 complicated by severe preeclampsia and placental abruption. METHODS. We analyzed the placenta for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) through molecular and immunohistochemical assays and by and electron microscopy and measured the maternal antibody response in the blood to this infection. RESULTS. SARS–CoV-2 localized predominantly to syncytiotrophoblast cells at the materno-fetal interface of the placenta. Histological examination of the placenta revealed a dense macrophage infiltrate, but no evidence for the vasculopathy typically associated with preeclampsia. CONCLUSION. This case demonstrates SARS–CoV-2 invasion of the placenta, highlighting the potential for severe morbidity among pregnant women with COVID-19. FUNDING. Beatrice Kleinberg Neuwirth Fund and Fast Grant Emergent Ventures funding from the Mercatus Center at George Mason University. The funding bodies did not have roles in the design of the study or data collection, analysis, and interpretation and played no role in writing the manuscript.
- 1 September 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (9) , 4947-4953
Top Cited PapersOpen AccessSARS–CoV-2 infection of the placenta
BACKGROUND. The effects of the novel coronavirus disease 2019 (COVID-19) in pregnancy remain relatively unknown. We present a case of second trimester pregnancy with symptomatic COVID-19 complicated by severe preeclampsia and placental abruption. METHODS. We analyzed the placenta for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) through molecular and immunohistochemical assays and by and electron microscopy and measured the maternal antibody response in the blood to this infection. RESULTS. SARS–CoV-2 localized predominantly to syncytiotrophoblast cells at the materno-fetal interface of the placenta. Histological examination of the placenta revealed a dense macrophage infiltrate, but no evidence for the vasculopathy typically associated with preeclampsia. CONCLUSION. This case demonstrates SARS–CoV-2 invasion of the placenta, highlighting the potential for severe morbidity among pregnant women with COVID-19. FUNDING. Beatrice Kleinberg Neuwirth Fund and Fast Grant Emergent Ventures funding from the Mercatus Center at George Mason University. The funding bodies did not have roles in the design of the study or data collection, analysis, and interpretation and played no role in writing the manuscript.
- 22 July 2020
- Published by Elsevier in Seminars in Perinatology
- Vol. 44 (7) , 151281
Consolidation of obstetric services in a public health emergency
- 22 July 2020
- Published by Elsevier in Seminars in Perinatology
- Vol. 44 (7) , 151281
Consolidation of obstetric services in a public health emergency
- Open Access
- 23 June 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (24) , 2520-2522
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
Developing an approach to care for pregnancy and childbirth during the coronavirus disease 2019 (COVID-19) crisis is a priority to (1) provide safe care to pregnant women and newborns; and (2) protect health care workers from infection. A study conducted in New York City reported a 13.5% prevalence of asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in women presenting for childbirth.1 On March 30, 2020, an initially asymptomatic woman admitted to the Yale New Haven Health system developed cough and fever soon after childbirth; testing confirmed SARS-CoV-2 infection. This event prompted the development of a SARS-CoV-2 screening and testing program of patients presenting for childbirth; we report the prevalence detected in the first weeks of the program.
- 23 June 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (24) , 2520-2522
Open AccessPrevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
Developing an approach to care for pregnancy and childbirth during the coronavirus disease 2019 (COVID-19) crisis is a priority to (1) provide safe care to pregnant women and newborns; and (2) protect health care workers from infection. A study conducted in New York City reported a 13.5% prevalence of asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in women presenting for childbirth.1 On March 30, 2020, an initially asymptomatic woman admitted to the Yale New Haven Health system developed cough and fever soon after childbirth; testing confirmed SARS-CoV-2 infection. This event prompted the development of a SARS-CoV-2 screening and testing program of patients presenting for childbirth; we report the prevalence detected in the first weeks of the program.
- 3 December 2019
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 39 (4) , 190
Hospital Variation in Utilization and Success of Trial of Labor After a Prior Cesarean
(Am J Obstet Gynecol. 2019;220:98.e1–98.e14) Although elective repeat cesarean is commonly performed to prevent uterine rupture during labor and other complications, cesarean delivery carries risks for mother and fetus, including increased risk of maternal and neonatal morbidity. Trial of labor after cesarean (TOLAC) delivery is recommended by the American College of Obstetricians and Gynecologists for women with no contraindications. The practice of TOLAC can be influenced by factors such as provider litigation concerns, patient preference and hospital support. The aim of this study was to understand varying utilization of TOLAC in California hospitals and how this affected patient outcomes. In addition, institutional characteristics associated with varying TOLAC utilization and success rates were analyzed.
- 3 December 2019
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 39 (4) , 190
Hospital Variation in Utilization and Success of Trial of Labor After a Prior Cesarean
(Am J Obstet Gynecol. 2019;220:98.e1–98.e14) Although elective repeat cesarean is commonly performed to prevent uterine rupture during labor and other complications, cesarean delivery carries risks for mother and fetus, including increased risk of maternal and neonatal morbidity. Trial of labor after cesarean (TOLAC) delivery is recommended by the American College of Obstetricians and Gynecologists for women with no contraindications. The practice of TOLAC can be influenced by factors such as provider litigation concerns, patient preference and hospital support. The aim of this study was to understand varying utilization of TOLAC in California hospitals and how this affected patient outcomes. In addition, institutional characteristics associated with varying TOLAC utilization and success rates were analyzed.
- Open Access
- 16 October 2019
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 10 (05) , 879-887
Evaluating the Impact of a New Smartphone Texting Tool on Patient Care in Obstetrics, an Emergent Healthcare Setting
Background Hospitals across the country are investing millions of dollars to adopt new Health Insurance Portability and Accountability Act (HIPAA)-compliant secure text messaging systems. However, in nearly all cases, these implementations are occurring without evaluation of their impact on patient care. Objective To evaluate perceived impact on patient care and workflow of new text messaging system implemented in obstetrics at Yale-New Haven Hospital and to inform guidelines for future implementations in emergent settings. Methods A new HIPAA-compliant texting system was implemented in obstetrics in 2016. Before implementation of the new system, residents and nurses were surveyed on perceived effect of communication system (pagers with text receiving, service mobile phones, personal cell phones) on clinical workflow and patient care using 5-point Likert scale and open-ended questions. Following roll-out (1 and 6 months), both teams were surveyed with same questions. Results were compared using Wilcoxon–Mann–Whitney test (0–1 months and then 0–6 months). Open-ended question results were qualitatively compared for recurrent unifying themes. Results In both nursing and resident domains, 1 month after implementation, the new communication system was perceived to significantly improve efficiency and patient care across all metrics. After 6 months, this effect decayed in nearly all categories (including efficiency, real-time communication, and knowledge of covering provider). The exception was nurse's knowledge of which resident to contact and resident's timely evaluation of patient, for which we observed sustained improvements. System shortcomings identified included interrupted connection (i.e., dropped calls), dysfunctional and inaccurate alert system, and unclear identification of the covering provider. Conclusion A new text-messaging–based communication system may improve efficiency and patient care in emergent settings, but system shortcomings can substantially erode potential benefits over time. We recommend implementers evaluate new systems for a set of specific functional requirements to increase probability of sustained improvement and decrease risk of poor patient outcomes.
- 16 October 2019
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 10 (05) , 879-887
Open AccessEvaluating the Impact of a New Smartphone Texting Tool on Patient Care in Obstetrics, an Emergent Healthcare Setting
Background Hospitals across the country are investing millions of dollars to adopt new Health Insurance Portability and Accountability Act (HIPAA)-compliant secure text messaging systems. However, in nearly all cases, these implementations are occurring without evaluation of their impact on patient care. Objective To evaluate perceived impact on patient care and workflow of new text messaging system implemented in obstetrics at Yale-New Haven Hospital and to inform guidelines for future implementations in emergent settings. Methods A new HIPAA-compliant texting system was implemented in obstetrics in 2016. Before implementation of the new system, residents and nurses were surveyed on perceived effect of communication system (pagers with text receiving, service mobile phones, personal cell phones) on clinical workflow and patient care using 5-point Likert scale and open-ended questions. Following roll-out (1 and 6 months), both teams were surveyed with same questions. Results were compared using Wilcoxon–Mann–Whitney test (0–1 months and then 0–6 months). Open-ended question results were qualitatively compared for recurrent unifying themes. Results In both nursing and resident domains, 1 month after implementation, the new communication system was perceived to significantly improve efficiency and patient care across all metrics. After 6 months, this effect decayed in nearly all categories (including efficiency, real-time communication, and knowledge of covering provider). The exception was nurse's knowledge of which resident to contact and resident's timely evaluation of patient, for which we observed sustained improvements. System shortcomings identified included interrupted connection (i.e., dropped calls), dysfunctional and inaccurate alert system, and unclear identification of the covering provider. Conclusion A new text-messaging–based communication system may improve efficiency and patient care in emergent settings, but system shortcomings can substantially erode potential benefits over time. We recommend implementers evaluate new systems for a set of specific functional requirements to increase probability of sustained improvement and decrease risk of poor patient outcomes.
- 1 January 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 220 (1) , 98.e1-98.e14
Hospital variation in utilization and success of trial of labor after a prior cesarean
- 1 January 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 220 (1) , 98.e1-98.e14
Hospital variation in utilization and success of trial of labor after a prior cesarean